Norfolk Medical was incorporated in 1981 with the emphasis on significantly altering the vascular access community with the vascular access port.

Since then, Norfolk Medical has continued to provide innovative products to the healthcare community for more than two decades.

Below is a synopsis of Norfolk Medical's historical highlights
over those two decades.

1981 Incorporated in Chicago, Illinois
1982 First human implant of a “new” vascular access port
1983 First with FDA approval for a vascular access port
the MediPort™
1984 First with FDA approval for blood withdrawal through a port
1984 First with FDA approval for a 9 French “Hickman” catheter
attached to a port
1985 Peritoneal access port FDA approved
the NorPort™
1985 First clinical study for drainage of recurrent pleural effusion
the PleuralPort™
1986 First with a dual lumen access port
the Norport – DL™
1987 First with a port designed specifically for continuous infusion
the Norport – SP™
1989 Low profile single and dual lumen access ports
the Betaport™ & the BetaPort DL™
1991 First and only port with the patented “omni-directional access”
septum and“clear flow” technology
the OmegaPort™
1992 Dual lumen and peritoneal OmegaPort
the OmegaPort – DL™ & OmegaPort – PT™
1993 First “clear flow” external central venous line
the OmegaCath™
1996 First with “clear-flow” chamber port
the Vortex™
1998 Vascular access product line acquired by Horizon Medical Products
1999 Clearview “Sub-Q”™ Infusion Set launched
2001 Aqua-C Hydration System™ designed for Hypodermoclysis
HISTORICAL HIGHLIGHTS